| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Revenue | $2.19B | -3.9% |
| Cost of Revenue | $1.95B | -2.3% |
| R&D Expense | $13.0M | -13.3% |
| SG&A Expense | $107.0M | -2.7% |
| Operating Income | -$141.0M | -304.3% |
| Pre-tax Income | -$135.0M | -287.5% |
| Income Tax | $19.0M | -44.1% |
| Net Income | -$154.0M | -505.3% |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230.0M | +24.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $359.0M | +8.8% |
| Inventory | $259.0M | +6.6% |
| Current Assets | $886.0M | +6.4% |
| Total Assets | $2.81B | -7.3% |
| Current Liabilities | $457.0M | +12.6% |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $192.0M | -25.3% |
| Capital Expenditures | $72.0M | -18.2% |
| Investing Cash Flow | -$39.0M | +55.7% |
| Financing Cash Flow | -$109.0M | +48.1% |
| Free Cash Flow | $120.0M | -29.0% |
| Total Liabilities |
| $668.0M |
| +4.9% |
| Stockholders' Equity | $2.14B | -10.5% |